AR and neoplasm: It is more commonly associated with hormone-receptor-positive breast cancer, where AR expression is seen in >70% of tumours, and some small studies have shown AR expression in 30% (n = 13 of 43) of BRCA1mut and 78% (n = 14 of 18) of BRCA2mut tumours [63].